Evidence map›Paper›PMID 42457786›Full record

ArticleScientific reports2026

Chitosan-quinoxaline Schiff base hydroxyapatite composite with antimicrobial properties for bone regeneration.

Abdelrahman Barakat, Gameel A M Ehagali, Shahira H El-Moslamy, Moustafa S Abusaif, Medhat E Owda, Yousry A Ammar, Mohamed B Ghazy

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdelrahman BarakatDepartment of Chemistry, Faculty of Science (boys), Al-Azhar University, Nasr City, Cairo, 11884, Egypt. dr_abdelrahman@azhar.edu.eg.ORCID 0000-0002-4123-0342
Gameel A M EhagaliDepartment of Chemistry, Faculty of Science (boys), Al-Azhar University, Nasr City, Cairo, 11884, Egypt. elhag1970@azhar.edu.eg.
Shahira H El-MoslamyBioprocess Development Department (BID), Genetic Engineering and Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg El-Arab City, 21934, Alexandria, Egypt.
Moustafa S AbusaifDepartment of Chemistry, Faculty of Science (boys), Al-Azhar University, Nasr City, Cairo, 11884, Egypt.
Medhat E OwdaDepartment of Chemistry, Faculty of Science (boys), Al-Azhar University, Nasr City, Cairo, 11884, Egypt.
Yousry A AmmarDepartment of Chemistry, Faculty of Science (boys), Al-Azhar University, Nasr City, Cairo, 11884, Egypt.
Mohamed B GhazyDepartment of Chemistry, Faculty of Science (boys), Al-Azhar University, Nasr City, Cairo, 11884, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Implant-associated infections remain a major challenge in bone regeneration, often compromising the long-term success of hydroxyapatite-based biomaterials. A new sulfonated quinoxaline aldehyde, 2-ethoxy-4-formylphenyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-sulfonate (B6), was synthesized and covalently grafted onto chitosan via Schiff base condensation to yield derivatives with controlled degrees of substitution (d1-d4). Which were subsequently incorporated into hydroxyapatite to form composite systems (dH0-dH4). Structural characterization using Fourier-transform infrared spectroscopy (FTIR), nuclear magnetic resonance (NMR), X-ray diffraction (XRD), and X-ray photoelectron spectroscopy (XPS) confirmed successful Schiff base formation, while thermogravimetric analysis (TGA) indicated enhanced thermal stability. Scanning electron microscopy with energy-dispersive X-ray analysis (SEM-EDX) and Brunauer-Emmett-Teller (BET) analyses revealed homogeneous hydroxyapatite dispersion and a mesoporous architecture (44.8 m

Indexed as

Anti-Infective AgentsBone RegenerationChitosanDurapatiteQuinoxalinesAnimalsAnti-Bacterial AgentsBiocompatible MaterialsChlorocebus aethiopsMicrobial Sensitivity TestsSchiff BasesSpectroscopy, Fourier Transform InfraredStaphylococcus aureusX-Ray DiffractionAnti-Bacterial AgentsAnti-Infective AgentsBiocompatible MaterialsChitosanDurapatiteQuinoxalinesSchiff BasesBone regenerationChitosan Schiff baseHydroxyapatite

Identifiers

PMID42457786
PMCPMC13373163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.